EDGAR Filing Documents for 0001571049-15-001620

Form 8-K - Current report:

SEC Accession No. 0001571049-15-001620

Filing Date

2015-03-04

Accepted

2015-03-04 12:07:23

Documents

Period of Report

2015-03-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	t1500497_8-k.htm	8-K	21968
2	EXHIBIT 1.1	t1500497_ex1-1.htm	EX-1.1	41555
3	EXHIBIT 5.1	t1500497_ex5-1.htm	EX-5.1	10920
4	EXHIBIT 10.1	t1500497_ex10-1.htm	EX-10.1	184229
5	EXHIBIT 99.1	t1500497_ex99-1.htm	EX-99.1	12167
6	EXHIBIT 99.2	t1500497_ex99-2.htm	EX-99.2	12184
7	GRAPHIC	ex1-1logo.jpg	GRAPHIC	12592
8	GRAPHIC	ex5-1logo.jpg	GRAPHIC	7269
9	GRAPHIC	ex99-1logo1.jpg	GRAPHIC	11663
10	GRAPHIC	ex99-1logo2.jpg	GRAPHIC	4453
11	GRAPHIC	ex99-2logo1.jpg	GRAPHIC	11663
12	GRAPHIC	ex99-2logo2.jpg	GRAPHIC	4453
	Complete submission text file	0001571049-15-001620.txt		356945

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922

Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330

Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)